ARL9 and colon adenocarcinoma: As seen in Fig. 4, the 5-year survival rate of patients with high ARL9 mRNA expression levels in colon adenocarcinoma tissues was significantly lower than that of patients with low expression levels (P < 0.05); their 5-year survival rates were 51.4% and 72.2%, respectively.